Contains viable, selected strains of human adenovirus type 4 and human adenovirus type 7 prepared in human-diploid fibroblast cell cultures (strain wi-38); virus strains have not been attenuated; cells are grown and the virus growth maintained in dulbecco's modified eagle's medium, fetal bovine serum, and sodium bicarbonate; approved for use in military populations 17-50 years of age; indicated for active immunization for the prevention of febrile acute respiratory disease caused by adenovirus type 4 and type 7; carton consists of one bottle of 100 tablets adenovirus type 4 (ndc 51285-174-02) and one bottle of 100 tablets adenovirus type 7 (ndc 51285-175-02); store refrigerated between 2-8 degrees c (35-46 degrees f); do not freeze; keep bottle tightly closed and protect from moisture; do not remove desiccant canister from bottle; prescription only; for oral administration; dosage: one tablet of adenovirus type 4 component and one tablet of adenovirus type 7 component
NSN 2925-00-794-5937
NSN 5915-01-555-4239
NSN 5990-01-442-3520
NSN 5945-01-057-7430
NSN 5930-00-051-9048
NSN 6610-00-106-3401
NSN 5996-00-350-7957
NSN 5985-01-284-1556
NSN 2925-00-572-0454
NSN 5855-01-157-7186
NSN 5855-01-284-3500
NSN 5975-00-991-7189